Search Results
Lori A. Leslie, MD, speculates on how CAR-T cell therapy may be combined to treat lymphomas
Lori A. Leslie, MD, on how CAR-T cell therapy has impacted the treatment of B-cell lymphomas
Does bridging therapy affect lymphoma CAR-T outcomes?
What are the driving forces in patient selection for CAR T-cell therapy in aggressive lymphoma?
The role of bridging and timing in CAR-T
Lori A. Leslie, MD, elaborates on recent outcomes from the CLL14 trial
Rationale for Treating Marginal Zone Lymphoma With PI3K-Delta Inhibitor Umbralisib
Lorenz Trumper, MD, speaks on the differences between B-Cell and T-Cell lymphomas
CAR T-cell therapy updates in CLL
AutoSCT vs CAR-T for patients with relapsed LBCL in PR: the role of total metabolic tumor volume
CLL & CAR-T: the intricacies and potential
Dr. Feldman Discusses the Difficulties of Rare Lymphomas
